Regulation of cell volume is critical for the body’s cells, f. e. during cellular exposure to fluids of varying salt concentrations, in cell division, cell growth, but also in diseases such as cancer, stroke and myocardial infarction.
A certain chloride channel, a membrane protein that allows the passage of the chloride ion, is of crucial importance in volume regulation. It is activated by the swelling of the cell and then releases chloride ions and organic matter (osmolytes) from the cell. Researchers in Berlin-Buch have now succeeded for the first time in elucidating the molecular identity of this volume-regulated anion channel (VRAC) (Science Express, DOI: 10.1126/science.1252826)*.
Researchers led by Professor Thomas J. Jentsch (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch/Leibniz-Institut für Molekulare Pharmakologie, FMP) identified a molecule, LRRC8A, which is an essential constituent of the volume-regulated anion channel (VRAC). This protein needs to be assembled with related proteins (LRRC8B to E) to form channels with probably six subunits.
They could also show for the first time that these chloride channels are also permeable to small organic molecules such as taurine or amino acids. For over 20 years, research groups across the globe have been seeking to elucidate the molecular structure of the volume-regulated anion channel (VRAC). It took Jentsch’s team almost four years to achieve this breakthrough.
The regulation of cell volume is important for many functions in the organism. The volume-regulated anion channel (VRAC) which Thomas Jentsch and his coworkers Felizia Voss and Tobias Stauber now identified at the molecular level is expressed in all vertebrate cells.
If a particular cell volume is exceeded, the channel opens and permits the outflow of osmolytes such as chloride ions as well as small organic molecules such as taurine and amino acids. By contrast, cations such as potassium or sodium cannot permeate.
Once the channel is opened, chloride and other osmolytes pass in a passive process called diffusion. Due to its biophysical properties the channel only allows anions and certain organic compounds to pass. Thus, the cell reduces the concentration of its osmolytically active constituents to (or even below) that of the surrounding fluid. At the same time, the water content of the cell decreases as the water molecules flow out via aquaporins in the cell membrane. The volume of the cell decreases again.
LRRC8A was discovered as a VRAC component using a genome-wide RNA interference (siRNA) screen in collaboration with Katina Lazarow and Jens von Kries from the FMP Screening Unit. By means of short RNA snippets, the translation of the genetic information into the corresponding proteins can be suppressed. Using a one-by-one approach in a large-scale cell culture experiment, the Berlin group transiently silenced the products of all approximately 20,000 human genes.
In an automated screening process the researchers investigated which of the genes are required for the swelling-activated anion flux across the cell membrane. The approximately 130,000 time-dependent ion flux measurements were statistically analyzed with help from the Bioinformatics Group of the MDC (Nancy Mah/Miguel Andrade-Navarro).
The essential role of LRRC8 proteins in the volume-regulated anion channel was verified using CRISPR/Cas technology, which just became available during the past two years. With this method, specific genes on the chromosomes can be disrupted completely. Different combinations of LRRC8 proteins, all including the obligate LRRC8A, – either by omitting some of the family members from gene disruption or by reconstituting different combinations – led to different electrophysiological properties of the channel. “This allows us to explain the behavior of the channel in different tissues which until now had remained elusive,” Thomas Jentsch said.
"Cells can swell or in the worst case even burst. Water transport and content must therefore be tightly regulated," he added. Water transport is always driven by the osmotic gradient. Cells take up chloride from their surroundings, whereas organic substances such as taurine or amino acids are produced within the cells.
Deciphering the molecular structure of this chloride channel may also pave the way for better medical treatments, for example, after stroke. "In the case of damage in the brain, cells swell and release glutamate, which acts upon receptors on nerve cells. The subsequent inflow of calcium raises the intracellular concentration of this ion to toxic levels," Jentsch said. With the onset of programmed cell death (apoptosis) during cancer chemotherapy, however, there is a strong reduction in cell volume. The volume-regulated chloride channel also appears to be involved in this process.
*Identification of LRRC8 Heteromers as Essential Component of the Volume-regulated Anion Channel VRAC.
Felizia K. Voss1,2,3, Florian Ullrich1,2,3, Jonas Münch1,2,3, Katina Lazarow1, Darius Lutter1,2,3, Nancy Mah2, Miguel A. Andrade-Navarro2, Jens P. von Kries1, Tobias Stauber1,2 * and Thomas J. Jentsch1,2,4 *
*Correspondence to: Jentsch@fmp-berlin.de (T.J.J.); firstname.lastname@example.org (T.S.).
1Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin
2Max Delbrück Center for Molecular Medicine (MDC), Berlin
3Graduate program of the Freie Universität Berlin
4Neurocure, Charité Universitätsmedizin, Berlin
Science Express, 10. April 2014; DOI: 10.1126/science.1252826
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
Leibniz-Institut für Molekulare Pharmakologie
im Forschungsverbund Berlin e.V. (FMP)
13125 Berlin, Germany
The Max Delbrück Center for Molecular Medicine (MDC) is one of 18 research centers of the Helmholtz Association. It was founded in 1992 to link basic molecular basic research with clinical research. The MDC is working closely with the Charité - University Medicine in the Berlin Institute of Health (BIH) and has evolved in recent years into an internationally recognized research institute.
The Leibniz-Institut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), a federation of eight institutes in Berlin in the field of natural, life and environmental sciences with a staff of more than 1500 employees. The multiple award-winning institutions are members of the Leibniz Association. The Forschungsverbund came into being in 1992 in a unique historical situation as the successor organization of the former Academy of Sciences of the GDR.
Barbara Bachtler | Max-Delbrück-Centrum
Embryonic development: How do limbs develop from cells?
18.05.2018 | Humboldt-Universität zu Berlin
Reading histone modifications, an oncoprotein is modified in return
18.05.2018 | American Society for Biochemistry and Molecular Biology
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology